MiR-629 promotes human pancreatic cancer progression by targeting FOXO3

Quercetin-induced miR-200b-3p regulates the mode of self-renewing divisions in pancreatic cancer

(2017) Clifford C. Nwaeburu et al.   Molecular Cancer

Evidence for the role of microRNA 374b in acquired cisplatin resistance in pancreatic cancer cells

(2016) R Schreiber et al.   CANCER GENE THERAPY

Survival of Patients with Gastrointestinal Cancers Can Be Predicted by a Surrogate microRNA Signature for Cancer Stem–like Cells Marked by DCLK1 Kinase

(2016) Nathaniel Weygant et al.   CANCER RESEARCH

Insights into a Critical Role of the FOXO3a-FOXM1 Axis in DNA Damage Response and Genotoxic Drug Resistance

(2016) Gabriela Nestal de Moraes et al.   CURRENT DRUG TARGETS

Downregulated miR-506 expression facilitates pancreatic cancer progression and chemoresistance via SPHK1/Akt/NF-κB signaling

(2016) J Li et al.   ONCOGENE

Up-regulation of microRNA let-7c by quercetin inhibits pancreatic cancer progression by activation of Numbl

(2016) Clifford C. Nwaeburu et al.   Oncotarget

Small-Molecule ONC201/TIC10 Targets Chemotherapy-Resistant Colorectal Cancer Stem-like Cells in an Akt/Foxo3a/TRAIL-Dependent Manner

(2015) V. V. Prabhu et al.   CANCER RESEARCH

Integrated molecular analysis to investigate the role of microRNAs in pancreatic tumour growth and progression

(2015) Adam E Frampton et al.   LANCET

Projecting Cancer Incidence and Deaths to 2030: The Unexpected Burden of Thyroid, Liver, and Pancreas Cancers in the United States

(2014) L. Rahib et al.   CANCER RESEARCH

Reprogramming ovarian and breast cancer cells into non-cancerous cells by low-dose metformin or SN-38 through FOXO3 activation

(2014) Theodore Hu et al.   Scientific Reports

FOXO3a Is a Major Target of Inactivation by PI3K/AKT Signaling in Aggressive Neuroblastoma

(2013) E. E. Santo et al.   CANCER RESEARCH

Role and regulation of the forkhead transcription factors FOXO3a and FOXM1 in carcinogenesis and drug resistance

(2013) Ana R. Gomes et al.   Chinese Journal of Cancer

MicroRNA profiling and prediction of recurrence/relapse-free survival in stage I lung cancer

(2012) Yan Lu et al.   CARCINOGENESIS

An endothelial apelin-FGF link mediated by miR-424 and miR-503 is disrupted in pulmonary arterial hypertension

(2012) Jongmin Kim et al.   NATURE MEDICINE

p53 regulates epithelial–mesenchymal transition and stem cell properties through modulating miRNAs

(2011) Chun-Ju Chang et al.   NATURE CELL BIOLOGY

Role of eIF3a in regulating cisplatin sensitivity and in translational control of nucleotide excision repair of nasopharyngeal carcinoma

(2011) R-Y Liu et al.   ONCOGENE

FOXO3a represses VEGF expression through FOXM1-dependent and -independent mechanisms in breast cancer

(2011) C T Karadedou et al.   ONCOGENE

Octamer 4 (Oct4) mediates chemotherapeutic drug resistance in liver cancer cells through a potential Oct4-AKT-ATP-binding cassette G2 pathway

(2010) Xiao Qi Wang et al.   HEPATOLOGY

MicroRNA-20a Overexpression Inhibited Proliferation and Metastasis of Pancreatic Carcinoma Cells

(2010) Haijiao Yan et al.   HUMAN GENE THERAPY

An elegant miRror: microRNAs in stem cells, developmental timing and cancer

(2009) Rachael A. Nimmo et al.   CHROMOSOMA

The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs

(2009) Ulrich Wellner et al.   NATURE CELL BIOLOGY

ERK promotes tumorigenesis by inhibiting FOXO3a via MDM2-mediated degradation

(2008) Jer-Yen Yang et al.   NATURE CELL BIOLOGY

Many forks in the path: cycling with FoxO

(2008) K K Ho et al.   ONCOGENE